Back to Our Recipients

Aaron Haubner

University of Kentucky, Lexington, KY

Sponsor: Peter A. Crooks

This project will utilize cloned human cell lines that express a variety o nicotine receptors to pharmacologically evaluate and determine the mechanism of potential drg candidates. The goal is to establish experimental protocols that will eventually replace the use of animals in nicotine drug activities and mechanism screens, as well as improve experimental assay precision and predictability.